• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高分辨率HLA分型在非亲缘脐血移植中的应用]

[Application of high resolution HLA typing in unrelated umbilical cord blood transplantation].

作者信息

Yang Shuo, He Jun, Li Yang, Xu Chao, Bao Xiao-Jing, Yuan Xiao-Ni, Qiu Hui-Ying, Jin Zheng-Ming, Tang Xiao-Wen, Fu Cheng-Cheng, Han Yue, Ma Xiao, Wu De-Pei, Sun Ai-Ning

机构信息

Jiangsu Instiute of Hematology, The First Affiliated Hospial of Soochow University; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou 215006, Jiangsu Province, China.

Jiangsu Instiute of Hematology, The First Affiliated Hospial of Soochow University; Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou 215006, Jiangsu Province, China. E-mail:

出版信息

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):125-30. doi: 10.7534/j.issn.1009-2137.2014.01.025.

DOI:10.7534/j.issn.1009-2137.2014.01.025
PMID:24598664
Abstract

This study was purposed to investigate the clinical value of HLA matching(low and high resolution) and its effect on outcome of the patients received umbilical cord blood transplantation(UCBT). Sequence-specific oligonucleotide probe (SSOP) , sequence-based typing (SBT) and sequence-specific primers(SSP) were used to perform high resolution HLA matching for HLA-A, -B, -Cw, -DRB1, -DQB1 and low resolution for HLA-A, B, DRB1 among 34 patients with hematologic malignancies who received unrelated UCB transplantation and grafts. The effects of HLA matching (low or high resolution ) on leading engraftment, hematopoietic reconstitution, graft-versus-host disease (GVHD) and infection after UCB transplantation were analyzed by comparison. The results showed that the median of total nucleated cells (TNC) of transplanted cord blood was 6.0×10(7)/kg, The time of neutrophil recovery was significantly shortened when more than 5×10(7)/kg TNC were transplanted (P < 0.05). The HLA-(6-10)/10 group of high resolution HLA matching was better than the HLA (4-5)/10 group in the respect of leading engraftment, the time of platelet recovery and the rate of acute GVHD (P < 0.05). In contrast, HLA-I+II locus, HLA-DRB1 or HLA-DQB1 locus mismatch could prolong the platelet engraftment time (P < 0.05). There was statistical difference in the time of platelet recovery, the rate of acute GVHD between the HLA (5-6)/6 group of low resolution HLA matching and the HLA (3-4)/6 group after UCB transplantation (P < 0.05), but the mismatch locus of HLA with low resolution did not correlate with the time of platelet recovery (P > 0.05). It is concluded that the high resolution HLA matching between patients received unrelated UCB transplantation and grafts may contribute to select the better UCB, that has important clinical value to promote hematopoietic reconstitution and to reduce the complications after UCB transplantation.

摘要

本研究旨在探讨人类白细胞抗原(HLA)配型(低分辨率和高分辨率)的临床价值及其对接受脐带血移植(UCBT)患者预后的影响。采用序列特异性寡核苷酸探针(SSOP)、序列分型(SBT)和序列特异性引物(SSP)对34例接受非亲缘脐血移植及移植物的血液系统恶性肿瘤患者进行HLA-A、-B、-Cw、-DRB1、-DQB1的高分辨率HLA配型及HLA-A、B、DRB1的低分辨率配型。通过比较分析HLA配型(低分辨率或高分辨率)对脐血移植后造血干细胞植入、造血重建、移植物抗宿主病(GVHD)及感染的影响。结果显示,移植脐血有核细胞总数(TNC)中位数为6.0×10⁷/kg,当移植TNC超过5×10⁷/kg时,中性粒细胞恢复时间明显缩短(P<0.05)。高分辨率HLA配型的HLA-(6-10)/10组在造血干细胞植入、血小板恢复时间及急性GVHD发生率方面优于HLA(4-5)/10组(P<0.05)。相反,HLA-I+II位点、HLA-DRB1或HLA-DQB1位点错配可延长血小板植入时间(P<0.05)。低分辨率HLA配型的HLA(5-6)/6组与HLA(3-4)/6组在脐血移植后血小板恢复时间、急性GVHD发生率方面存在统计学差异(P<0.05),但低分辨率HLA错配位点与血小板恢复时间无关(P>0.05)。结论:接受非亲缘脐血移植及移植物患者间的高分辨率HLA配型有助于选择更好的脐血,对促进造血重建及减少脐血移植后并发症具有重要临床价值。

相似文献

1
[Application of high resolution HLA typing in unrelated umbilical cord blood transplantation].[高分辨率HLA分型在非亲缘脐血移植中的应用]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):125-30. doi: 10.7534/j.issn.1009-2137.2014.01.025.
2
[The impact of HLA matching on outcome of single unit unrelated cord blood transplantation: a retrospective single center clinical analysis].[人类白细胞抗原匹配对单单位非血缘脐血移植结局的影响:一项回顾性单中心临床分析]
Zhonghua Xue Ye Xue Za Zhi. 2014 Aug;35(8):678-83. doi: 10.3760/cma.j.issn.0253-2727.2014.08.002.
3
HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.非亲属脐血移植中HLA-C与HLA-DQB1的相容性
Haematologica. 1999 Jun;84(6):530-4.
4
Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.多个单位 HLA 不匹配、性别不匹配的脐带血移植用于晚期血液系统恶性肿瘤。
Stem Cells Dev. 2007 Feb;16(1):177-86. doi: 10.1089/scd.2006.06500-HB.
5
[Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases].25例血液病患者非血缘脐血移植的临床研究
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):767-73. doi: 10.7534/j.issn.1009-2137.2014.03.036.
6
[Correlative analysis between HLA high resolution typing and GVHD in 48 cases received unrelated umbilical cord blood transplantation].[48例非亲缘脐血移植患者HLA高分辨分型与移植物抗宿主病的相关性分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Feb;14(1):116-8.
7
[Results of unrelated umbilical cord blood stem cell transplantation for 65 patients in China].[中国65例非亲缘脐血干细胞移植结果]
Zhonghua Er Ke Za Zhi. 2006 Mar;44(3):220-3.
8
Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.血液系统恶性肿瘤患者接受无关供者脐带血移植与骨髓或外周血造血干细胞移植的疗效比较:单中心分析。
Chin Med J (Engl). 2013 Jul;126(13):2499-503.
9
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.人类白细胞抗原差异和移植物淋巴细胞对成人脐血移植后同种异体植入及生存的影响。
Br J Haematol. 2007 Nov;139(3):464-74. doi: 10.1111/j.1365-2141.2007.06824.x.
10
[Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].[来自非亲属供体的脐带血细胞移植:双重移植]
Methods Find Exp Clin Pharmacol. 2010 Dec;32 Suppl A:47-51.